Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
FDA approves an ADHD drug as the first treatment for binge-eating disorder
WASHINGTON – Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder.
The Food and Drug Administration first approved Vyvanse as a once-a-day pill for attention deficit hyperactivity disorder in 2007. On Friday the agency cleared the drug for adults who compulsively overeat.
Regulators approved the new use based on two studies in which adults with a history of binge eating had fewer instances per week while taking Vyvanse, compared with those getting a placebo.
Side effects of the drug, made by Shire PLC, can include psychiatric problems like hallucinations and mania as well as heart complications.
Shire PLC is an Irish-headquartered company based on the island of Jersey.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
